Top 50 Medical Device Startup Investors in Belgium in January 2025
A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical device startups based in Belgium. We rank investors based on the number of investments they made in Medical device companies from Belgium. We update this investor list every month.Top 50 Medical Device Startup Investors in Belgium in January 2025
Investor | Medical Device Belgium investments |
---|---|
PMV | 5 |
S.R.I.W. | 5 |
Capricorn Partners | 5 |
White Fund | 3 |
Newton Biocapital | 3 |
Pierre Rigaux | 3 |
Meusinvest (Noshaq) | 3 |
Namur Invest | 3 |
Amazon Alexa Fund | 2 |
UI Investissement | 2 |
Kurma Partners | 2 |
Theodorus III | 2 |
Qbic Fund | 2 |
New Science Ventures | 2 |
GoBeyond | 2 |
WING by Digital Wallonia | 2 |
Inventures SA | 2 |
Spinventure | 2 |
Spreds | 2 |
TCD Capital (ex TheClubDeal) | 2 |
Vives Louvain Technology Fund | 2 |
Sambrinvest | 2 |
Flanders Future Techfund | 1 |
Invest Mons Borinage Centre | 1 |
SFPI-FPIM | 1 |
Boehringer Ingelheim Venture Fund | 1 |
Yves Beudin | 1 |
Jean Dessain | 1 |
Eduardo Ronzano | 1 |
Sensinnovat | 1 |
Earlybird Venture Capital | 1 |
SoFi | 1 |
Lumiares | 1 |
EIC Fund | 1 |
Financière Spin-Off Luxembourgeoise | 1 |
EQT Life Sciences | 1 |
Nausicaa Ventures | 1 |
Carevolution | 1 |
New Rhein | 1 |
Pierre Drion | 1 |
Delta Partners | 1 |
Omega Funds | 1 |
Parana Management | 1 |
Fidimec | 1 |
LeanSquare | 1 |
Sofinex | 1 |
Manuardeo | 1 |
Invest BW | 1 |
Thuja Capital | 1 |
Fonds Vives II (University of Louvain, UCL) | 1 |
Do and dare company
Show more
Investment focus
- Software, Biotechnology, Health Care
- Series A, Seed, Series B
- Belgium, United States, The Netherlands
Portfolio highlights
- Apideck — Integrate and monitor APIs at warp speed. Apideck is the fastest way for developers to build integrations. Connect new APIs in minutes instead of days.
- Minze Health — Minze Health is a health tech start-up that builds creative digital health solutions for urology, pelvic health, and (in)continence care.
- PanTera — PanTera wants to bring a new hope to cancer patients by enabling the widespread use of radiopharmaceuticals for personalised treatment of tumors
The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century.
Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.
Show more
Investment focus
- Biotechnology, Health Care, Manufacturing
- Funding Round, Series A, Series B
- Belgium, United States, Spain
Portfolio highlights
- Univercells — We are biotech innovators, rooted in Belgium, driven by one purpose: To transform how biotech drugs are made so everyone, everywhere, can get them.
- Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
- Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more
Investment focus
- Biotechnology, Health Care, Software
- Funding Round, Series B, Series A
- Belgium, United States, The Netherlands
Portfolio highlights
- NEFFA — NEFFA The fashion industry is one of the most polluting in the world: the sector is responsible for 8 to 10% of global CO2 emissions and accounts for ~20% of industrial water contamination. Conventional materials such as cotton require an immense amount of resources, semi-finished products travel all over the globe for various steps in theproduction process, and overproduction is anchored in the fundaments of the business model of fashion brands.Through the NEFFA production method, design is done directly in 3D, offering an innovative way to rethink fashion design. A digital design interface offers options to apply all kinds of parametric textures in the blink of an eye. The final design is turned into an affordable and recyclable 3D mold with a variety of digital technologies. This is possible because the manufacturing method does not require any high heat or pressure so the molds can be like blisters. In the meantime, the biomass is grown in large fermentation tanks. NEFFA currently works with mycelium – creating a material called MycoTEX – but their system can also work with other biomaterials that can be grown through liquid fermentation, such as algae or even collagen.
- Thryve — Thryve’s SDK brings everything you need to access fragmented wearable, medical devices, and health data silos with a single integration. We unify your users’ data from smartwatches, blood glucose meters, and many other sources that unlock a continuous stream of harmonized health information for your care. We support popular data sources like AppleHealth, Google Fit, Huawei Health, Samsung Health, and many more.
- Minze Health — Minze Health is a health tech start-up that builds creative digital health solutions for urology, pelvic health, and (in)continence care.
For game changers in medtech
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Series B
- Belgium
Portfolio highlights
- Axithra — Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.
- Minze Health — Minze Health is a health tech start-up that builds creative digital health solutions for urology, pelvic health, and (in)continence care.
- Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Series A, Funding Round, Seed
- Belgium, Japan, France
Portfolio highlights
- AdipoPharma — By harnessing the power of the Adipocyte AdipoPharma is committed to developing innovative treatment for type 2 diabetes
- AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
- Tensegrity Pharma — Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.
Pierre Rigaux
Show more
Investment focus
- Sports, Medical Device
- Seed, Pre-Seed, Convertible Note
- Belgium
Portfolio highlights
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
Noshaq offers financial services to help businesses develop.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Funding Round
- Belgium, France, Germany
Portfolio highlights
- Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
- Get Your Way — Discover the future of assisted reality with Get Your Way's aRdent smart glasses. Perfect for SMEs looking for innovative solutions to improve their business
- Brenus Pharma — Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.
Namur Invest Group provides companies with financing solutions in various forms adapted to their needs, to strengthen their financial.
Show more
Investment focus
- Health Care, Medical Device, Auctions
- Series A, Seed, Funding Round
- Belgium
Portfolio highlights
- Invineo — Invineo design and development of a "smart machine" for catering and hospitality professionals.
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
- iSTAR Medical — iSTAR Medical is a medtech company delivering breakthrough eye care solutions through minimally-invasive implants with bio-integration.
The Amazon Alexa Fund is Amazon’s venture capital fund investing in artificial intelligence, frontier tech, voice, robotics, and digital health across consumer and enterprise. We invest in early- to growth-stage companies globally. To learn more, visit us at alexafund.com.
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Seed, Series A, Series B
- United States, United Kingdom, Canada
Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.
Show more
Investment focus
- Manufacturing, Software, Health Care
- Private Equity, Series A, Seed
- France, Spain, Canada
Portfolio highlights
- Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
- Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
- AdEchoTech — The company was the first to market a robotic tele-ultrasound solution, expanding the capabilities currently offered in the field of teleradiology.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Series A, Seed, Series B
- France, Switzerland, Spain
Portfolio highlights
- Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
- Omnidoc — Omnidoc is a tele-expertise platform for healthcare professionals to exchange medical opinions.
- Raidium — Radiology augmented GPT to tackle the complexity of precision medicine
Theodorus is the spin-off fund of Université Libre de Bruxelles that invests ininvest in early stage projects based on proprietary disruptive technologies.
Show more
Investment focus
- Health Care, Life Science, Medical
- Funding Round, Seed, Series A
- Belgium, Canada, France
Portfolio highlights
- DrugBank — DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.
- HYPNO VR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
- Cascador Health — Cascador Health bridges the gap between sources and users of healthcare data. Using curated, validated and anonymized RWD allows healthcare providers and life science industry to gain insights and provide better care.
The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.
Show more
Investment focus
- Biotechnology, Software, Health Care
- Seed, Funding Round, Series A
- Belgium
Portfolio highlights
- Weavely — Design forms in Figma - publish with Weavely. We turn your visual ideas into interactive, web-based forms.
- Flindr Therapeutics — Immagene develops personalized cancer immunotherapies to fight multiple cancer type.
- Confo Therapeutics — Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO® technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery. CONFO® body-stabilized active state conformationsof these receptors disclose previously inaccessible structural features empowering the discovery of novel agonists for better therapeutic intervention.
New Science Ventures is a venture capital firm that focuses on investments in life sciences and information technology companies. They invest in early and late stage companies taking novel scientific approaches to address significant unmet needs, while creating order-of-magnitude improvements in performances. The company also invests in companiesusing science-based innovations to address market needs in life sciences such as pharmaceuticals, biologics, medical devices, diagnostics, and IT. The team of the company expertise in strategy and corporate planning, operations and cost management, and leadership development.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series D
- United States, United Kingdom, Belgium
Portfolio highlights
- Glydways — Glydways, formerly Wayfarer is a transportation technology and clean energy company based in South San Francisco, California. It specializes in the design, manufacture, installation, and operation of affordable autonomous transportation for low, medium, and extremely high-capacity needs.
- Vuv Analytics — VUV Analytics was incorporated in Austin, TX in December 2009, as a spin-off from a semiconductor equipment company. The five founders bring with them critical and unique know-how related to the hardware, software, analysis, intellectual property, and marketing associated with VUV technologies. The team's past success in pioneering VUVreflectometry for use in the semiconductor metrology field yielded several key market wins and an extensive IP portfolio, including 32 issued patents and 12 pending patents.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.
Show more
Investment focus
- Information Technology, Medical, Software
- Funding Round, Seed, Series A
- Switzerland, Germany, United Kingdom
Portfolio highlights
- LEND — LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.
- AVAtronics — AVA Active Noise Cancellation (ANC) Solution is a breakthrough in Audio Industry. AVA is the first and only TRUE WIDE-BAND ANC in the market capable of selectively cancelling all annoying noises we want to get rid of without compromising the quality of Music or speech.
- Blumer — Blumer is a social networking platform that provides social networks that can monetize time by consuming advertisements, selling nfts, and making crypto transactions. It offers social networks, crypto, digital marketing, and blockchain.
W.IN.G by Digital Wallonia invests in SAAS, advanced tech and deep tech startups (AI, drones, medtech, IOT,...). W.IN.G brings smart money by helping startups by bi-weekly interactions and providing an operating teams (seasonal entrepreneurs being hands-on with the portfolio).
Show more
Investment focus
- Software, Health Care, Internet
- Seed, Convertible Note, Series A
- Belgium
Portfolio highlights
- IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
- Soil Capital Belgium — Discover Europe's first certified, multi-national carbon farming programme that rewards regenerative agriculture.
Inventures is a European venture capital fund that builds a better world through a portfolio of investments in sustainable businesses.The firm has two funds: Inventures I & Inventures II.Inventures was created to support early stage smart and innovative European businesses, to support sustainable job growth and empower entrepreneurs.Inventures empowers citizenship co-investments through a crowdfunding platform, MyMicroInvest.
Show more
Investment focus
- Health Care, Manufacturing, Biotechnology
- Series A, Seed, Funding Round
- Belgium, France, United Kingdom
Portfolio highlights
- BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
- myskillcamp — Myskillcamp is a digital learning platform and educational design support service. Myskillcamp supports their customers in the digital transformation of their company and the launch of their Digital Learning project. From the audit of needs to the design of engaging educational devices, through a pilot phase, they make a point of honor to adapt thedigital to the specificities of each and give it meaning.With their online platform, businesses can manage their learner communities and connect all their partners in one place. Their tool also allows businesses to structure training spaces by skills, trades, brands within camps. In parallel, businesses can create educational content from scratch, select a map in their marketplace, or plan sessions in-class. Businesses can organize the distribution of their training to a single learner or to a whole group.
- Octave — A sustainable, cost-effective and reliable energy storage system with second-life batteries from electric vehicles.
Spinventure supports the creation of spin-off companies that aim to industrialize and commercialize the result of scientific research. Spinventure was born from a collaboration between MEUSINVEST and the University of Liège.
It is headquartered in Angleur, Belgium.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Funding Round
- Belgium
Portfolio highlights
- Dim3 — Improve patients outcome - Deliver actionable insights - Save healthcare costs
- Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.
- Convert Pharmaceuticals — Convert Pharmaceuticals develops prodrugs that are inert upon administration to patients, but transform into potent anti-cancer agents upon entering tumors.
We empower high-potential entrepreneurship and democratize venture capital. Discover promising start-ups & SMEs and invest alongside business angels.
Show more
Investment focus
- Health Care, Information Technology, Food and Beverage
- Series A, Seed, Series B
- Belgium, France
Portfolio highlights
- Opinum — What is Opinum Data Hub? Our Data Hub is a secured Cloud-based platform that allows energy and environmental actors to centralise, enhance, analyse, and share data.
- Digiteal — Digiteal offers a wide range of services for e-invoice presentment, electronic payments and open banking.
- NietsCo — NietsCo. is the home of Botaniets Gin 0.0%, a leading selection of alcohol-free products, carefully distributed to the world's best restaurants, concept stores, shops and consumers.
TheClubDeal is an investment holding and fund manager co-investing into SME’s and real estate projects. It provides facilitation of governance between non-executive shareholders and entrepreneurs. Its governance structure, including its charter of avoidance of conflict of interests, is therefore paramount to the adequate management of the Company.At TheClubDeal, we connect Investors and Entrepreneurs around promising investment opportunities. For each of these, we will invest ourselves and co-invest with a selected number of investors. We add value by processing strong applied governance principles, when selecting and managing our investments, and by gathering the necessary skills to successfully grow the businesses and real-estate projects we co-invest in. TheClubDeal is launching their second fund, a 50M € PRIVAK/PRICAF in H1 2021 with the mandate to invest in Belgian scale-ups in three sectors: Smart Living, Tech and Life Sciences.
Show more
Investment focus
- Health Care, Biotechnology, Information Technology
- Series A, Series B, Seed
- Belgium, France
Portfolio highlights
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
- Inpulse — Inpulse is an automated supply management platform for restaurateurs.
- Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Vives is an interregional seed and early stage technology multi-sector fund. The new fund, initiated by UCLouvain, is a unique European inter-university fund having access to world class innovations from leading EU top universities.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Funding Round
- Belgium, France, United States
Portfolio highlights
- BOTALYS — BOTALYS uses an innovative Biomimetic Indoor Farming technology to recreate the ideal wild conditions for rare botanicals to grow in. We develop pristine & potent botanical ingredients for the Nutraceutical and Cosmetic industries.
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.
Show more
Investment focus
- Biotechnology, Health Care, Information Technology
- Seed, Series A, Series B
- Belgium, France, Spain
Portfolio highlights
- AdipoPharma — By harnessing the power of the Adipocyte AdipoPharma is committed to developing innovative treatment for type 2 diabetes
- AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
- ATB Therapeutics — ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
Flanders Future Techfund operates as an investment firm.
Show more
Investment focus
- Medical, Semiconductor, Clinical Trials
- Seed
- Belgium
Portfolio highlights
- Flindr Therapeutics — Immagene develops personalized cancer immunotherapies to fight multiple cancer type.
- Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
- Swave Photonics — Swave develops Spatial Computing, Holography, holographic chips, and holograms in the HXR chip to create 3D augmented and virtual reality and HUD Heads Up Displays
IMBC is particularly active in the agri-food, technology, and environmental sectors, with direct links to the ecosystems of the Mons Borinage region.
Show more
Investment focus
- Farming, Training, Wellness
- Seed, Pre-Seed, Series A
- Belgium
Portfolio highlights
- BiocSol — BiocSol focus on sustainable microbial-based crop protection.
- iQrypto — Quantum technologies for a more secure world.
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Funding Round, Series B, Series A
- Belgium, United States, France
Portfolio highlights
- Cohabs — We create sustainable & community-driven shared homes around the world for young workers and interns. Join our community.
- Univercells — We are biotech innovators, rooted in Belgium, driven by one purpose: To transform how biotech drugs are made so everyone, everywhere, can get them.
- Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
- Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
- Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
Yves Beudin
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Jean Dessain - Non Executive Director @ OneLIFE
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Eduardo Ronzano is the Co-Founder and CEO of Kolet. He previously worked at The Bradery as a Pre-Seed Investor. Eduardo Ronzano attended ESCP Business School.
Show more
Investment focus
- Software, SaaS, E-Commerce
- Seed, Pre-Seed, Angel
- France, United States, United Kingdom
Portfolio highlights
- Screeb — Make products your users will love by using Screeb, the all-in-one tool for Product Discovery. Product analytics, user recruitment, and more!
- Frak Labs — Manage your unified web identity, earn rewards, and interact seamlessly with partner websites using our passkey-first blockchain smart wallet.
- Poolside — The best code you never wrote.
Sensinnovat
Show more
Investment focus
- Medical, Diabetes, Health Care
- Series A, Series B
- Belgium
Portfolio highlights
- Indigo Diabetes — Revolutionizing the management of chronic disease.
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.
Show more
Investment focus
- Software, Information Technology, Health Care
- Series A, Seed, Series B
- Germany, United States, United Kingdom
Portfolio highlights
- GEMMABio — GEMMABio, a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases.
- Upvest — Upvest empowers financial institutions to offer investment products in their app with a modular, scalable, and accessible API. Upvest brings together everything that’s required to offer a broad range of investment products on the website and app. They are connected to the world’s leading asset providers and exchanges to provide the bestinvestments, at the best prices and execution speed.
- Briefcase — Briefcase automates the legwork in accounting so you can focus on growing your practice
SoFi is a finance company that offers a range of lending and wealth management services. The company primarily caters to early-stage professionals and offers variable and fixed rate parent, personal, and MBA loans, mortgage refinancing, and more. They create modern financial products and services that help people borrow, save, spend, invest, andprotect their money better so that they can achieve financial independence and realize their ambitions from owning a home to saving for retirement, paying off their student loans, and more.It was founded in 2016 and is headquartered in San Francisco, California.
Show more
Investment focus
- Apps, Biotechnology, Information Technology
- Series A, Funding Round, Seed
- Belgium, Brazil, United States
Portfolio highlights
- PieSync — PieSync creates deep integrations between web applications focused on business users. Our goal: increasing your productivity drastically by combining the powers of your favorite cloud applications
- Wage — Thanks for your interest in Wage.com - If you are interested in purchasing this domain, please click the button below to get in contact. Some Value Points for the domain: 1. Highly Aged (SEO Benefits) (Wage.com HAS BEEN ACTIVE SINCE 1996) 2. Highly Sought After (Value Appreciation) (
- Indigo Diabetes — Revolutionizing the management of chronic disease.
Guiding health technology towards a brighter future.
Show more
Investment focus
- Software, Health Care, Manufacturing
- Pre-Seed
- Belgium
Portfolio highlights
- Koios Care — Koios Care is a startup in the field of digital health. Their objective is to develop innovative and validated digital daily activity biomarkers in order to improve care while lowering costs.
- Nuclivision — Nuclivision is a company of experts assisting businesses, doctors and clinics all along the imaging workflow
start-ups, SMEs, technology, co-investment
Show more
Investment focus
- Biotechnology, Health Care, Information Technology
- Pre-Seed, Seed, Funding Round
- Germany, The Netherlands, Austria
Portfolio highlights
- Filuta AI — Operationalized Composite Artificial Intelligence
- Resistell AG — Resistell is a antibiotic resistance test.
- iThera Medical — Explore optoacoustic imaging technology for non-invasive in vivo visualization and quantification of disease-related tissue biomarkers.
Specializes in spin-off and spin-out investments.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Series A
- Belgium
Portfolio highlights
- Synergia Medical — Synergia Medical aims at developing and commercializing next generation neurostimulation devices. It relies on a seasoned management team with extensive experience in developing implantable neurostimulators.In only three years time, the company became ISO13485 certified, created and sold an OEM external neurostimulator for a motorized amputeeprosthesis arm and developed its first version of the NAOS platform.Supported by private investors and public research grants, the company has quickly grown to a team of thirteen highly skilled multidisciplinary professionals.
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, The Netherlands, Switzerland
Portfolio highlights
- PanTera — PanTera wants to bring a new hope to cancer patients by enabling the widespread use of radiopharmaceuticals for personalised treatment of tumors
- ATB Therapeutics — ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
- Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
A multi-industry early stage venture capital fund Nausicaa Ventures is an early stage investment fund organisation focused on investment rounds between EUR 1 and 4 million. Nausicaa Ventures was created in 2009 by bringing together 35 private investors and selected institutional investors, such as the European Investment Fund or ING Bank, under the management of ...
Show more
Investment focus
- Software, CRM, Big Data
- Series B, Funding Round
- Belgium
Portfolio highlights
- NGDATA — Unleash the potential of your customer data. Our AI-driven Intelligent Engagement Platform helps you create intelligent customer journeys and meaningful digital experiences.
- Ovizio — Optimize your process, control your CPPs & monitor quality while reducing hands-on time and risk of contamination.
Offers health consulting services
Show more
Investment focus
- Health Care, mHealth, Therapeutics
- Seed
- Belgium, United States
Portfolio highlights
- moveUP — Ontvang medische zorg op afstand voor en na uw operatie. moveUP is gespecialiseerd in de begeleiding van knie- en heupoperaties.
- Helpper — Helpper verbindt mensen die thuishulp zoeken voor dagelijkse taken, met hulpvaardige buurtbewoners die een centje willen bijverdienen.
- Neuroventis — Neuroventis emboldening people with neurological disorders. Learn how our technology is changing the world of neurological care.
New Rhein is a Philadelphia based healthcare venture capital firm focused on repurposed assets.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Series B, Series A, Seed
- United States, Israel, Belgium
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Corsair Pharma — Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients.
- Butterfly Medical — Butterfly, Butterfly Medical, BPH Treatment, BPH Office Procedure, Idan Geva, Minimally Invasive BPH, Prostate, Enlarged Prostate, Bening Prostate Hyperplasia, Urology
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Early stage VC investments and funding for start-ups / founders in Ireland.
Show more
Investment focus
- Software, Information Technology, Health Care
- Funding Round, Seed, Series A
- Ireland, United States, United Kingdom
Portfolio highlights
- Imvizar — Transform your buildings, office spaces, visitor attractions, and parks with an immersive and visual storytelling experience using augmented reality. Discover unique ways to tell your story at Imvizar.
- ZeroMission — ZeroMission is a technology focused provider of integrated data for intelligent fleet electrification planning, operations and reporting.
- MarketSizer — MarketSizer offers subscription-based competitive intelligence and market insights for SaaS vendors who want to strategically grow their business.
We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series A, Series C
- United States, Switzerland, United Kingdom
Portfolio highlights
- XII Medical — XII Medical is a medical device developer company. It develops a minimally invasive outpatient technology for the treatment of obstructive sleep apnea.
- Beta Bionics — Improving lives of people living with diabetes by helping to reduce the data and decision-making overload required with diabetes.
- Aviceda Therapeutics — Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases. The company focuses on the next generation of immunomodulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly. A combination ofcutting-edge technologies and deep biological insights form Aviceda’s engine of transformative product creation.Aviceda uses its cell-based high-throughput screening (HTS) platform to rapidly screen, select, and optimize ligands based on maximum affinity and specificity for each different type of innate immune cell. . The company's products are for eye diseases, fibrosis, neurology, and oncology, for eye diseases like AVD-104, AVD-302, AVD-401 for dry eye, diabetic retinopathy, and retinoblastoma respectively AVD-601, AVD-701 and AVD-801 for oncology, neurology, and fibrosis respectively.
Parana Management
Show more
Investment focus
- Medical, Diabetes, Health Care
- Series A, Series B
- Belgium
Portfolio highlights
- Indigo Diabetes — Revolutionizing the management of chronic disease.
Fidimec is a Belgium-based venture capital firm that offers investment and incubation services for seed stage startups.
Show more
Investment focus
- Industrial, Semiconductor, Medical
- Funding Round, Series A, Seed
- Belgium
Portfolio highlights
- Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
- Sentea — Sentea makes fibre optic Sensing affordable to the industry and enables continuous monitoring even in harsh environments.
- MICLEDI Microdisplays — MICLEDI Microdisplays is an experienced executive in the semiconductor industry,
New Economy Startups Investor & Accelerator
Show more
Investment focus
- Software, Music, Internet
- Seed, Funding Round, Series A
- Belgium, France, United States
Portfolio highlights
- e-peas — Ready to make your device energy autonomous with our state-of-art energy harvesting solutions? Phone: (+32) 10 77 12 30, sales@e-peas.com
- LinkByCar — LinkByCar specializes in leveraging artificial intelligence and sensor data from connected vehicles to predict mechanical issues accurately. The company aggregates data across various automotive manufacturers, offering comprehensive solutions as a neutral third party. This approach enables the anticipation of vehicle maintenance needs, enhancingthe driving experience by ensuring reliability and safety. LinkByCar's technology focuses on the personalization of driving experiences and supports the evolving landscape of mobility, including connected vehicles, autonomous driving, and carpooling. The company serves as a bridge between automotive data and actionable insights, catering to the needs of vehicle owners and manufacturers alike.
- Bridge.audio — Bridge is for everyone working with music and audio. We provide private workspaces to manage, share, and connect better
Sofinex is an investment comapny.
Show more
Investment focus
- Wellness, Lifestyle, Health Care
- Series A
- Belgium
Portfolio highlights
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Manuardeo is an early stage investments focused VC firm.
Show more
Investment focus
- Medical, Diabetes, Health Care
- Series A, Series B
- Belgium
Portfolio highlights
- Indigo Diabetes — Revolutionizing the management of chronic disease.
Invest BW is a funding program.
Show more
Investment focus
- Health Care, AgTech, Medical
- Series A, Seed, Series B
- Belgium
Portfolio highlights
- IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
- Minagro — Minagro develops high-quality green products for crop care. Minagro conducts research activities in confirmed proprietary technologies from green and specialty chemistries.
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Thuja Capital invests in early stage medical product innovations for diagnosis, cure, care or prevention.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Series A, Seed
- The Netherlands, Belgium, United States
Portfolio highlights
- Pan Cancer — Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer.
- Synerkine Pharma — Synerkine Pharma. Connecting Cytokines for the benefit of patients.
- Artica Therapeutics — Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.
Fonds Vives II (University of Louvain, UCL)
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Seed
- Belgium, United States
Portfolio highlights
- Virovet — Antiviral drugs and thermostable vaccines for livestock
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
- ITeos Therapeutics — iTeos Therapeutics is pioneering the discovery and development of highly differentiated immuno-oncology therapeutics for cancer patients.
Investors by industry
Consumer
Hardware
Climate
Proptech
Gaming
Google
Marketplace
Biotech
Impact
Community
Energy
FinTech
Artificial intelligence
Health Care
EdTech
Sustainability
Venture Capital
Real Estate
Retail
Clean Energy
Food and Beverage
B2B
Video Games
Web3
Photography
Education
Big Data
Finance
Financial Services
Payments
Beauty
Publishing
Infrastructure
Organic Food
Social Network
Social Media
Digital Media
Art
Medical
Android
Franchise
Mobile
Local
Music
Legal
Enterprise Software
eSports
Construction
Sports
Internet
Wellness
Email
Manufacturing
Recruiting
Mobile Advertising
Travel
Hospitality
Cannabis
Fitness
Biotechnology
Platforms
Wine And Spirits
Automotive
Social
Medical Device
Crowdfunding
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Film
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Germany
United Kingdom
Canada
United States
New Zealand
South Korea
Ireland
India
Australia
Africa
Sri Lanka
Europe
Middle East
China
Qatar
Vietnam
Estonia
Bermuda
Gibraltar
Belarus
Croatia
Ethiopia
Belize
Egypt
Georgia
France
Denmark
Costa Rica
Greece
Czech Republic
Hungary
Ecuador
Faroe Islands
Chile
Ghana
Finland
Bahrain
Algeria
Hong Kong
Belgium
Armenia
Bulgaria
Barbados
Liechtenstein
Oceania
Mauritius
Lithuania
Italy
Brazil
Philippines
Mali
Liberia
Jersey
Malaysia
Indonesia
Israel
Malta
Lebanon
Norway
Myanmar
Asia
Morocco
Peru
Nicaragua
South Africa
Mexico
Spain
Panama
Kuwait
Saudi Arabia
Senegal
Uruguay
Puerto Rico
Japan
Sweden
El Salvador
Sierra Leone
Uganda
Slovenia
Singapore
Taiwan
Togo
Seychelles
LATAM
Zambia
Venezuela
Tajikistan
Zimbabwe
Russian Federation
Dominican Republic
Turkey
Tunisia
Bahamas
Uzbekistan
Thailand
Rwanda
San Marino
Serbia
Tanzania
Iceland
Ukraine
Portugal
Poland
Namibia
Nigeria
United Arab Emirates
Jamaica
Honduras
Azerbaijan
Isle of Man
Bolivia
Iraq
Luxembourg
Jordan
Albania
Pakistan
Bangladesh
Argentina
Romania
Grenada
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Latvia
Oman
Cameroon
Austria
Switzerland
Colombia
Marshall Islands
Guatemala
Investors in Belgium by industry
Restaurants
InsurTech
Financial Services
Big Data
Cryptocurrency
Finance
Food and Beverage
Medical
Medical Device
Wellness
Consumer
Internet
Social Network
Manufacturing
Digital Media
Mobile
Blockchain
Non Profit
Legal
Construction
Software
Sports
Payments
Enterprise Software
Fitness
Hospitality
Automotive
Mobile Advertising
Recruiting
Platforms
Biotechnology
Enterprise
Health Care
Biotech
EdTech
Climate
Energy
Sustainability
Impact
SaaS
Proptech
Marketplace
Artificial intelligence
Community
Real Estate
Mobile Apps
Infrastructure
Fashion
Web3
B2B
Life Science
Photography
Publishing
Education
Clean Energy
Renewable Energy
Music
Transportation
Retail
FinTech
Social Media
Gaming
Media (entertainment)
CleanTech
Agriculture (agtech)
Hardware